Invention Application
![[1,2,4]TRIAZOLO[1,5-a]PYRIDINYL SUBSTITUTED INDOLE COMPOUNDS](/docs/US/2018-01-04/US20180000790A1/abs.jpg.600x600.jpg)
- Patent Title: [1,2,4]TRIAZOLO[1,5-a]PYRIDINYL SUBSTITUTED INDOLE COMPOUNDS
-
Application No.: US15635055Application Date: 2017-06-27
-
Publication No.: US20180000790A1Publication Date: 2018-01-04
- Inventor: Alaric J. Dyckman , Dharmpal S. Dodd , Tasir Shamsul Haque , Louis J. Lombardo , John E. Macor , Christopher P. Mussari , Laxman Pasunoori , Sreekantha Ratna Kumar , Trevor C. Sherwood , Shoshana L. Posy , Ramesh Kumar Sistla , Subramaya Hegde , Anupama Ramachandra
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Priority: IN201611022328 20160629
- Main IPC: A61K31/4196
- IPC: A61K31/4196 ; A61K45/06 ; A61K31/4427 ; C07D471/04 ; A61K31/437
![[1,2,4]TRIAZOLO[1,5-a]PYRIDINYL SUBSTITUTED INDOLE COMPOUNDS](/abs-image/US/2018/01/04/US20180000790A1/abs.jpg.150x150.jpg)
Abstract:
Disclosed are compounds of Formula (I) or a salt thereof, wherein R1, R2, R3, R4, R5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
Public/Granted literature
- US10071079B2 [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds Public/Granted day:2018-09-11
Information query
